Chinese authorities are investigating dozens of senior AstraZeneca (AZN) China executives amid an ongoing insurance fraud case, Yicai Global reports. According to a person familiar with the matter ...
The company declined to comment on the Yicai report but added, “If requested, we will fully cooperate with the Chinese authorities.” “As a matter of policy, we do not comment on speculative ...